Ubs Group Ag Capricor Therapeutics, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 124,717 shares of CAPR stock, worth $702,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,717

Previous 549,427 77.3%

Holding current value

$702,156

Previous $5.46 Million 83.41%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$5.94 - $11.42 $2.52 Million - $4.85 Million	-424,710 Reduced 77.3%	124,717 $905,000
Q2 2025 Aug 14, 2025	BUY	$6.34 - $14.23 $989,572 - $2.22 Million	156,084 Added 39.68%	549,427 $5.46 Million
Q1 2025 May 13, 2025	BUY	$9.49 - $16.11 $2.57 Million - $4.36 Million	270,525 Added 220.26%	393,343 $3.73 Million
Q4 2024 Feb 14, 2025	BUY	$12.9 - $21.99 $1.42 Million - $2.41 Million	109,700 Added 836.26%	122,818 $1.7 Million
Q3 2024 Nov 14, 2024	BUY	$3.56 - $15.21 $15,774 - $67,395	4,431 Added 51.01%	13,118 $199,000

Q2 2024 Aug 13, 2024	BUY	$4.63 - $7.09 $33,275 - $50,955	7,187 Added 479.13%	8,687 $41,000
Q1 2024 May 13, 2024	BUY	$3.61 - $6.88 $5,415 - $10,320	1,500 New	1,500 $10,000
Q1 2023 May 12, 2023	BUY	$3.78 - $5.03 $16,779 - $22,328	4,439 New	4,439 $18,000
Q2 2022 Aug 10, 2022	BUY	$2.89 - $4.51 $64,915 - $101,303	22,462 Added 326.01%	29,352 $102,000
Q1 2022 May 16, 2022	BUY	$2.83 - $5.68 $8,891 - $17,846	3,142 Added 83.83%	6,890 $23,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.16 $10,831 - $15,591	3,748 New	3,748 $11,000
Q3 2021 Nov 15, 2021	SELL	$3.8 - $5.23 $7,303 - $10,052	-1,922 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.16 - $5.72 $4,888 - $8,848	1,547 Added 412.53%	1,922 $10,000
Q1 2021 May 12, 2021	SELL	$3.63 - $7.93 $17,064 - $37,278	-4,701 Reduced 92.61%	375 $2,000
Q4 2020 Feb 11, 2021	BUY	$3.43 - $5.23 $10,893 - $16,610	3,176 Added 167.16%	5,076 $17,000
Q3 2020 Nov 12, 2020	BUY	$4.08 - $9.81 $3,672 - $8,829	900 Added 90.0%	1,900 $10,000
Q2 2020 Jul 31, 2020	SELL	$1.0 - $8.5 $439 - $3,731	-439 Reduced 30.51%	1,000 $5,000
Q1 2020 May 01, 2020	SELL	$0.94 - $2.02 $3,735 - $8,027	-3,974 Reduced 73.42%	1,439 $2,000
Q4 2019 Feb 14, 2020	BUY	$1.04 - $3.55 $5,365 - $18,314	5,159 Added 2031.1%	5,413 $7,000
Q3 2019 Nov 14, 2019	BUY	$2.38 - $6.23 $604 - $1,582	254 New	254 $1,000

Others Institutions Holding CAPR

# of Institutions

141

Shares Held

13.3M

Call Options Held

Put Options Held

2.76M

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $137M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account